Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Non-Current Debt: 2018-2025

Historic Non-Current Debt for Dr Reddys Laboratories (RDY) over the last 8 years, with Mar 2025 value amounting to $92.0 million.

  • Dr Reddys Laboratories' Non-Current Debt rose 27.78% to $92.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $92.0 million, marking a year-over-year increase of 27.78%. This contributed to the annual value of $92.0 million for FY2025, which is 27.78% up from last year.
  • Latest data reveals that Dr Reddys Laboratories reported Non-Current Debt of $92.0 million as of FY2025, which was up 27.78% from $72.0 million recorded in FY2024.
  • Dr Reddys Laboratories' 5-year Non-Current Debt high stood at $92.0 million for FY2025, and its period low was $16.0 million during FY2023.
  • Over the past 3 years, Dr Reddys Laboratories' median Non-Current Debt value was $72.0 million (recorded in 2024), while the average stood at $60.0 million.
  • Its Non-Current Debt has fluctuated over the past 5 years, first skyrocketed by 405.88% in 2021, then plummeted by 78.95% in 2023.
  • Over the past 5 years, Dr Reddys Laboratories' Non-Current Debt (Yearly) stood at $86.0 million in 2021, then dropped by 11.63% to $76.0 million in 2022, then crashed by 78.95% to $16.0 million in 2023, then surged by 350.00% to $72.0 million in 2024, then increased by 27.78% to $92.0 million in 2025.